Online edition of India's National Newspaper
Friday, Jan 17, 2003

About Us
Contact Us
Business
News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment | Obituary |

Business Printer Friendly Page   Send this Article to a Friend

Ranbaxy Q4 net up

NEW DELHI JAN. 16. Ranbaxy Laboratories and its subsidiaries, recorded consolidated sales of Rs. 1,091.30 crores ($225 million) and Rs. 3,832 croes ($789 million) for the quarter (Q4) and the year ended December 31, 2002 respectively.

Net consolidated sales, after deducting trade discounts, were Rs. 1,058.90 crores ($218 million) and Rs. 3,711.30 crores ($764 million) for Q4 and the year 2002, reflecting a growth of 31 per cent and 39 per cent respectively over the corresponding periods of 2001.

Consolidated profit after tax was Rs.191.70 crores ($39 million) in Q4 and Rs. 608.40 crores ($125 million) in the year ended December 31, 2002 (conversion at Rs. 48.59 a dollar)

In Q4, Ranbaxy Laboratories recorded sales of Rs. 808.80 crores (Rs. 569 crores), registering a growth of 42 per cent. Net Sales at Rs. 776.40 crores grew by 45 per cent. Export sales at Rs. 547.10 crores (Rs. 308.60 crores) registered 77 per cent growth. R&D expenditure (including regulatory expenditure for Q4) was Rs. 47.10 crores (Rs. 17.40 crores). The profit before extraordinary items and tax has spurted to Rs. 220.30 crores from Rs. 60.30 crores) and the net profit after tax to Rs. 212.70 crores (Rs. 50.30 crores).

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment | Obituary |


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu